Taiwan-based vaccine maker Adimmune Corp. on Tuesday said it has signed an agreement with the World Health Organization (WHO) to receive early biological samples of emerging influenza variants.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Science & Tech
SEMI boasts largest SEMICON Taiwan to open in September
08/24/2025 09:43 PM - Society
Magnitude 4.8 earthquake shakes eastern Taiwan
08/24/2025 09:40 PM - Politics
Senior DPP legislative caucus officials step down after recall defeat
08/24/2025 09:10 PM - Business
Taiwanese firms eye Texas, but rising costs pose challenges
08/24/2025 07:33 PM - Society
Taiwan-based American influencer arrested, released over trespassing
08/24/2025 07:24 PM